Oncology © 2023
Still an opportunity to avail of this education - until 15th December 2023.
The 9th annual Oncology Update was held in Oxford. This virtual study day is for doctors and nurses, general practitioners, and pharmacists caring for people with cancer. Great feedback - see it below.
You can gain access to the videos and powerpoint slides - a valuable opportunity to support your learning in the specialties of Oncology and Haematology which are changing at pace. Keeping up to date with advances enables better care of our patients and their families. The aim of this course is to provide an opportunity for participants to update their knowledge on tumour sites - we run a rolling programme over a three year cycle.
I look forward to welcoming you to this exciting and informative day.
Look out for 10th annual course on 27.09.2024
Educational Credits: 5 Credits (Ref: 144730)
Virtual educational event
Chairs: Dr Matt Carey & Dr Mary Miller
Dr Rene Roux, Consultant Medical Oncologist, Oxford University Hospitals NHS Foundation Trust - Update on Gynaecological Malignancies
Dr Miranda Payne, Consultant Medical Oncologist, Oxford University Hospitals NHS Foundation Trust Payne - Update on Melanoma
Dr Thomas Carter, Consultant Medical Oncologist, Mount Vernon Cancer Centre - Update on Brain Tumours
Dr Charlotte Fribbens, Consultant Medical Oncologist, The Royal Marsden Hospital London - Update on Upper Gastro-intestinal
Dr Tim Cooksley, Consultant Acute Medicine, Manchester University NHS Foundation Trust and The Christie NHS Foundation Trust - Acute Medicine and Oncology
+ Course Programmes
08:50 Welcome and Introduction
09:00 Update of Melanoma - Dr Miranda Payne
10:10 Update on Brain Tumours - Dr Thomas Carter
11:10 Coffee/Tea Break
11:20 Update on upper Gastro-intestinal Cancers - Dr Charlotte Fribbens
12:50 Update on Gynaecological Malignancies - Dr Rene Roux
14:00 Acute Medicine and Oncology - Dr Tim Cooksley
15.00 Wrap up
+ Course Aims
Following the study day participants will:
- Have gained a deeper understanding of the current management of the tumour sites considered
- Be able to use the knowledge gained to help with the management of patients
- Be able to use new knowledge to aid in prognostication
- Have had an opportunity to ask questions and engage with the speakers to enable the translation of knowledge into practice